Allspring Global Investments
OVID icon

Allspring Global Investments’s Ovid Therapeutics OVID Stock Holding History

Allspring Global Investments’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.8K Hold
11,262
– – ﹤0.01% 1696
2025
Q4 		$18.7K Hold
11,262
– – ﹤0.01% 1656
2025
Q3 		$15.4K Sell
11,262
-27,025
-71% -$23.4K ﹤0.01% 1613
2025
Q2 		$12.1K Buy
+38,287
New +$11.5K ﹤0.01% 1607
2023
Q4 		– Sell
-6,294
Closed -$24.2K – 2591
2023
Q3 		$24.2K Buy
+6,294
New +$22.6K ﹤0.01% 2468

Other funds holding OVID

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Allspring Global Investments's OVID Position: Q1 2026 in Review

Allspring Global Investments held its Ovid Therapeutics (OVID) position steady in Q1 2026 at 11,262 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1696.

Allspring Global Investments first reported a position in OVID in Q3 2023 and has held it in 5 quarters since. The position peaked at $24.2K in Q3 2023. 103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

  • Allspring Global Investments held 11,262 shares of Ovid Therapeutics worth $23.8K as of Q1 2026.
  • Allspring Global Investments left its Ovid Therapeutics share count unchanged in Q1 2026.
  • Ovid Therapeutics made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1696 holding.
  • Allspring Global Investments first reported a position in Ovid Therapeutics in Q3 2023 and has held it in 5 quarters since.
  • Allspring Global Investments's Ovid Therapeutics position peaked at $24.2K in Q3 2023.
  • 103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.